Literature DB >> 19154781

Role of endothelial nitric oxide synthetase in arteriogenesis after stroke in mice.

X Cui1, M Chopp, A Zacharek, C Zhang, C Roberts, J Chen.   

Abstract

Arteriogenesis supports restored perfusion in the ischemic brain and improves long-term functional outcome after stroke. We investigate the role of endothelial nitric oxide synthetase (eNOS) and a nitric oxide (NO) donor, (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl) amino] diazen-1-ium-1, 2-diolate (DETA-NONOate), in promoting arteriogenesis after stroke. Adult wild-type (WT, n=18) and eNOS-knockout (eNOS(-/-), n=36) mice were subjected to transient (2.5 h) right middle cerebral artery occlusion (MCAo) and were treated with or without DETA-NONOate (0.4 mg/kg) 24 h after MCAo. Functional evaluation was performed. Animals were sacrificed 3 days after MCAo for arterial cell culture studies, or 14 days for immunohistochemical analysis. Consistent with previous studies, eNOS(-/-) mice exhibited a higher mortality rate (P<0.05, n=18/group) and more severe neurological functional deficit after MCAo than WT mice (P<0.05, n=12/group). Decreased arteriogenesis, was evident in eNOS(-/-) mice compared with WT mice, as demonstrated by reduced vascular smooth muscle cell (VSMC) proliferation, arterial density and diameter in the ischemic brain. eNOS(-/-) mice treated with DETA-NONOate had a significantly decreased mortality rate and improved functional recovery, and exhibited enhanced arteriogenesis identified by increased VSMC proliferation, and upregulated arterial density and diameter compared to eNOS(-/-) mice after stroke (P<0.05, n=12/group). To elucidate the mechanisms underlying eNOS/NO mediated arteriogenesis, VSMC migration was measured in vitro. Arterial cell migration significantly decreased in the cultured common carotid artery (CCA) derived from eNOS(-/-) mice 3 days after MCAo compared to WT arterial cells. DETA-NONOate-treatment significantly attenuated eNOS(-/-)-induced decrease of arterial cell migration compared to eNOS(-/-) control artery (P<0.05; n=6/group). Using VSMC culture, DETA-NONOate significantly increased VSMC migration, while inhibition of NOS significantly decreased VSMC migration (P<0.05; n=6/group). Our data indicated that eNOS not only promotes vascular dilation but also increases VSMC proliferation and migration, and thereby enhances arteriogenesis after stroke. Therefore, increase eNOS may play an important role in regulating of arteriogenesis after stroke.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19154781      PMCID: PMC2743134          DOI: 10.1016/j.neuroscience.2008.12.055

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  53 in total

Review 1.  The pathophysiology of the collateral circulation (arteriogenesis).

Authors:  I Buschmann; W Schaper
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

Review 2.  Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease.

Authors:  N van Royen; J J Piek; I Buschmann; I Hoefer; M Voskuil; W Schaper
Journal:  Cardiovasc Res       Date:  2001-02-16       Impact factor: 10.787

3.  Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model.

Authors:  Saeid Babaei; Duncan J Stewart
Journal:  Cardiovasc Res       Date:  2002-07       Impact factor: 10.787

4.  Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia.

Authors:  Zheng Gang Zhang; Li Zhang; Wayne Tsang; Hamid Soltanian-Zadeh; Daniel Morris; Ruilan Zhang; Anton Goussev; Cecylia Powers; Thomas Yeich; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2002-04       Impact factor: 6.200

5.  Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis).

Authors:  D Scholz; W Ito; I Fleming; E Deindl; A Sauer; M Wiesnet; R Busse; J Schaper; W Schaper
Journal:  Virchows Arch       Date:  2000-03       Impact factor: 4.064

6.  Collateral growth and angiogenesis around cortical stroke.

Authors:  L Wei; J P Erinjeri; C M Rovainen; T A Woolsey
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

7.  Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF.

Authors:  A Jozkowicz; J P Cooke; I Guevara; I Huk; P Funovics; O Pachinger; F Weidinger; J Dulak
Journal:  Cardiovasc Res       Date:  2001-09       Impact factor: 10.787

8.  Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats.

Authors:  J Chen; Y Li; L Wang; M Lu; X Zhang; M Chopp
Journal:  J Neurol Sci       Date:  2001-08-15       Impact factor: 3.181

9.  The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis.

Authors:  N Kee; S Sivalingam; R Boonstra; J M Wojtowicz
Journal:  J Neurosci Methods       Date:  2002-03-30       Impact factor: 2.390

10.  Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia.

Authors:  Robert S Smith; Kuei-Fu Lin; Jun Agata; Lee Chao; Julie Chao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-08-01       Impact factor: 8.311

View more
  29 in total

1.  Oxidative/nitrosative stress in rats subjected to focal cerebral ischemia/reperfusion.

Authors:  Hiba A Awooda; Mohamed F Lutfi; Gihan M Sharara G; Amal M Saeed
Journal:  Int J Health Sci (Qassim)       Date:  2015-01

2.  Impaired Cognitive Performance in Endothelial Nitric Oxide Synthase Knockout Mice After Ischemic Stroke: A Pilot Study.

Authors:  Shanshan Li; Yao Wang; Ze Jiang; Yaping Huai; James K Liao; Kaari A Lynch; Ross Zafonte; Lisa J Wood; Qing Mei Wang
Journal:  Am J Phys Med Rehabil       Date:  2018-07       Impact factor: 2.159

3.  Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury.

Authors:  Xiaoquan Rao; Jixin Zhong; Shu Zhang; Yushan Zhang; Qilin Yu; Ping Yang; Mong-Heng Wang; David J Fulton; Huidong Shi; Zheng Dong; Daowen Wang; Cong-Yi Wang
Journal:  Circulation       Date:  2011-06-13       Impact factor: 29.690

4.  Proof of concept: endogenous antiangiogenic factors predict the occurrence of symptomatic vasospasm post subarachnoid hemorrhage.

Authors:  Fernando D Testai; Venkatesh Aiyagari; Maureen Hillmann; Sepideh Amin-Hanjani; Glyn Dawson; Philip Gorelick
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

5.  Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke.

Authors:  Xu Cui; Michael Chopp; Alex Zacharek; Cynthia Roberts; Mei Lu; Smita Savant-Bhonsale; Jieli Chen
Journal:  Neurobiol Dis       Date:  2009-07-08       Impact factor: 5.996

Review 6.  Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Remodeling.

Authors:  Shuai Yuan; Christopher G Kevil
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

7.  Temporal patterns of blood flow and nitric oxide synthase expression affect macrophage accumulation and proliferation during collateral growth.

Authors:  Hendrik B Sager; Ralf Middendorff; Kim Rauche; Joachim Weil; Wolfgang Lieb; Heribert Schunkert; Wulf D Ito
Journal:  J Angiogenes Res       Date:  2010-09-16

8.  Neuroprotective Effects of Simvastatin and Cilostazol in L-Methionine-Induced Vascular Dementia in Rats.

Authors:  Ahmed M El-Dessouki; Mai A Galal; Azza S Awad; Hala F Zaki
Journal:  Mol Neurobiol       Date:  2016-08-20       Impact factor: 5.590

9.  Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway.

Authors:  Prasanna K Venkatesh; Christopher B Pattillo; Billy Branch; Jay Hood; Steven Thoma; Sandra Illum; Sibile Pardue; Xinjun Teng; Rakesh P Patel; Christopher G Kevil
Journal:  Cardiovasc Res       Date:  2010-01-08       Impact factor: 10.787

Review 10.  Nitric oxide: considerations for the treatment of ischemic stroke.

Authors:  Nicole A Terpolilli; Michael A Moskowitz; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-15       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.